XML 35 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
3 Months Ended
Mar. 31, 2018
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Three Months Ended
 
March 31, 2017
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by operating activities
$
4,316

 
$
24,580

 
$
18,744

 
$

 
$
47,640

Investing activities:

 

 

 

 

Capital expenditures

 
(1,487
)
 
(3,003
)
 

 
(4,490
)
Dividends received from subsidiaries

 
16,979

 

 
(16,979
)
 

Other

 
(14,834
)
 
4,398

 
10,469

 
33

Net cash provided by (used in) investing activities

 
658

 
1,395

 
(6,510
)
 
(4,457
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings
2,220

 
167,299

 
164,118

 
(14,834
)
 
318,803

Repayments

 
(190,665
)
 
(180,265
)
 
4,365

 
(366,565
)
Repurchases of common stock
(6,536
)
 

 

 

 
(6,536
)
Increase in bank overdrafts

 
4,062

 

 

 
4,062

Dividends paid by subsidiaries

 

 
(16,979
)
 
16,979

 

Other

 
(452
)
 

 

 
(452
)
Net cash used in financing activities
(4,316
)
 
(19,756
)
 
(33,126
)
 
6,510

 
(50,688
)
Effect of exchange rate changes on cash and cash equivalents

 

 
374

 

 
374

Net change in cash and cash equivalents

 
5,482

 
(12,613
)
 

 
(7,131
)
Cash and cash equivalents at the beginning of period

 
41,552

 
68,579

 

 
110,131

Cash and cash equivalents at the end of period
$

 
$
47,034

 
$
55,966

 
$

 
$
103,000

 
Condensed Consolidating Statement of Cash Flows
 
Three Months Ended
 
March 31, 2018
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
5,497

 
$
57,694

 
$
(10,198
)
 
$

 
$
52,993

Investing activities:

 

 

 

 

Capital expenditures

 
(2,954
)
 
(4,708
)
 

 
(7,662
)
Dividends received from subsidiaries

 
22,744

 

 
(22,744
)
 

Other

 
(18,908
)
 
(8,760
)
 
18,908

 
(8,760
)
Net cash provided by (used in) investing activities

 
882

 
(13,468
)
 
(3,836
)
 
(16,422
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings

 
58,000

 
515,663

 
(22,744
)
 
550,919

Repayments
(3,836
)
 
(90,000
)
 
(477,220
)
 
3,836

 
(567,220
)
Repurchases of common stock
(1,661
)
 

 

 

 
(1,661
)
Decrease in bank overdrafts

 
(10,575
)
 

 

 
(10,575
)
Dividends paid by subsidiaries

 

 
(22,744
)
 
22,744

 

Other

 
(290
)
 

 

 
(290
)
Net cash (used in) provided by financing activities
(5,497
)
 
(42,865
)
 
15,699

 
3,836

 
(28,827
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(1,800
)
 

 
(1,800
)
Net change in cash and cash equivalents

 
15,711

 
(9,767
)
 

 
5,944

Cash and cash equivalents at the beginning of period

 
50,602

 
67,351

 

 
117,953

Cash and cash equivalents at the end of period
$

 
$
66,313

 
$
57,584

 
$

 
$
123,897